Overview / Abstract: |
Schizophrenia is a serious and debilitating disorder that often poses a considerable challenge to clinicians. While long-acting injectables (LAIs) have emerged as a viable means to address patient nonadherence – often a component of schizophrenia management – clinicians often fail to implement the use of LAIs. Many times this is due to clinicians not being aware of updates such as the introduction of LAIs with increased dosing intervals, knowledge that is an important aspect of narrowing practice gaps in the treatment of this clinically complex disorder. For the first episode in this three-part CMEOcast podcast series on schizophrenia, expert faculty translate the latest data on the impact of LAIs vs. oral therapies in relapse prevention and rapid symptom reduction. |
Expiration |
Nov 21, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE |
Format |
Online, Podcast |
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)TM/contact hours/CEUs |
Accreditation |
ACCME, AANP, AAPA, ACPE, MACRA, ABIM, |
Presenters / Authors / Faculty |
Christoph U. Correll, MD |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Alkermes, Inc. |
Keywords / Search Terms |
CME Outfitters, LLC schizophrenia, mental health, psychiatry, neuroscience, psych Free CE CME |